Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03729804
Title Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA) ((COBRA))
Acronym (COBRA)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.